he participants provided informed c

he participants provided informed consent before they were aware of their group assignment and before they were assessed. Before giving their consent, patients were offered a general overview of the aims and characteristics of the study and interventions. They were informed that they would be participating voluntarily and that they could withdraw at any time, with the guarantee that they would continue to receive the treatment considered most appropriate by their doctor. Data collection involved no risk to the participants. A patient was considered to have withdrawn from the trial if he or she withdrew informed consent, the researcher felt that he or she should withdraw from the study for safety reasons, or the researcher felt it to be in the best interest of the patient.

結果 (繁體中文) 1:

他們知道他們的小組作業之前，他參加者提供知情同意和他們進行了評估之前。給他們的同意前，患者提出的目標和研究和干預的特點的概述。他們被告知，他們將自願參與，他們可以在任何時候退出，以保證他們能繼續得到考慮他們的醫生最適當的治療。數據收集不涉及風險的參與者。病人被認為已經從試驗退出，如果他或她退出了知情同意書，研究人員認為，他或她應該退出研究為安全起見，還是研究人員認為這是病人的最佳利益。

結果 (繁體中文) 2:

參與者在瞭解其小組分配之前和評估之前提供了知情同意。在給予同意之前，向患者提供研究和干預的目的和特點的概述。他們被告知，他們將自願參加，他們可以隨時參加，並保證他們將繼續接受醫生認為最考慮的治療。資料收集對參與者沒有風險。如果病人撤回同意，認為他或她出於安全原因應該退出研究，或者感覺研究者認為該研究符合病人的最佳利益，則被認為已退出試驗。